Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Literature affirms that patients are more likely to consistently take SGLT2i and GLP-1 agonist therapy with a lower prescription co-payment, resulting in improved patient adherence to American Diabetes Association (ADA) guideline directed therapy options [2]
Consultations: Schedule consultations to discuss health situations and ask questions
Majchrzak KM, Pupim LB, Flakoll PJ, Ikizler TA
Our approach includes: Thorough case evaluation using our medical and legal expertise Collaboration with top medical experts for case building and testimony A track record of success in complex pharmaceutical cases National reach through class actions and partnerships with other firms Were committed to holding pharmaceutical companies accountable and fighting for fair compensation for our clients
Schmitt B, Vicenzi M, Garrel C, Denis FM
